Novo Nordisk just showed 25% average weight loss with CagriSema in women with overweight or obesity. That number is going to get the headline, but underneath it is a finding that may hit much closer to home for millions of women who have watched their bodies change through menopause and been told some version of, “That’s just what happens when you get o…
CagriSema’s 25% Weight Loss in Women Is Only Half the Story
Novo Nordisk’s latest CagriSema data put a big number on the board, but the more interesting signal may be what happened when researchers looked at women across menopause.
New to On The Pen? Start with The Weekly Dose podcast for the weekly breakdown.
